Tamoxifen

CHEMBL83 Phase 4 Onaylandı Small molecule
Half-Life
5-7 days
Bioavailability
Protein Binding
Molecular Weight
371.5 g/mol
LogP
7.1
Phase
4

This medication blocks estrogen receptors in breast tissue and is widely used to treat and reduce the risk of hormone receptor-positive breast cancer in both women and men. It is typically taken as a daily tablet for five to ten years as part of a long-term cancer prevention or treatment plan. Regular gynecologic check-ups are recommended because it can have estrogen-like effects on the uterus.

Moleküler Ağırlık

371,5150 g/mol

LogP

7,10

TPSA

12,50 Ų

Lipinski RO5

Geçer

Terapötik Alanlar

İlaç Sınıfları

Etki Mekanizması

Selective estrogen receptor modulator (SERM).

Pharmacokinetics (PK)

Half-Life 5-7 days

Pharmacodynamics (PD)

Mekanizma

Selective estrogen receptor modulator (SERM).

2D Yapı

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1

InChI

InChI=1S/C26H29NO/c1-4-25(21-11-7-5-8-12-21)26(22-13-9-6-10-14-22)23-15-17-24(18-16-23)28-20-19-27(2)3/h5-18H,4,19-20H2,1-3H3/b26-25-

Molecular Formula

C26H29NO

HBD / HBA

- / 2

Döndürülebilir Bağlar

8

Ağır Atomlar

28

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

This medication blocks estrogen receptors in breast tissue and is widely used to treat and reduce the risk of hormone receptor-positive breast cancer in both women and men. It is typically taken as a daily tablet for five to ten years as part of a long-term cancer prevention or treatment plan. Regular gynecologic check-ups are recommended because it can have estrogen-like effects on the uterus.

Selective estrogen receptor modulator (SERM).

Key pharmacokinetic parameters for Tamoxifen: Half-life: 5-7 days.

Yes, Tamoxifen is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

Related Drugs

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL83. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 2733526. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.